Literature DB >> 10527931

Novel bimodal effects of the G-protein tissue transglutaminase on adrenoreceptor signalling.

J Zhang1, J Tucholski, M Lesort, R S Jope, G V Johnson.   

Abstract

Tissue transglutaminase (tTG) is a novel G-protein that previous studies showed can couple ligand-bound activated alpha(1B) adrenoreceptors to phospholipase C-delta, resulting in phosphoinositide (PI) hydrolysis. In human neuroblastoma SH-SY5Y cells we found that although endogenous tTG can facilitate alpha(1B) adrenoreceptor-stimulated PI hydrolysis, its contribution is minor compared with the classical heterotrimeric G-protein G(q/11). Further, we show that the alpha(1B) adrenoreceptor recruits tTG to the membrane and that this recruitment is enhanced by agonist occupancy of the receptor. In addition, the effects of tTG on signalling are bimodal. At low expression levels, tTG enhanced alpha(1B) adrenoreceptor-stimulated PI hydrolysis, whereas at higher expression levels tTG attenuated significantly this response. These findings are the first to demonstrate that a protein can both facilitate and attenuate receptor-stimulated PI hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10527931      PMCID: PMC1220584     

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  51 in total

1.  Transglutaminase activity is increased in Alzheimer's disease brain.

Authors:  G V Johnson; T M Cox; J P Lockhart; M D Zinnerman; M L Miller; R E Powers
Journal:  Brain Res       Date:  1997-03-21       Impact factor: 3.252

Review 2.  Heterotrimeric G proteins.

Authors:  H E Hamm; A Gilchrist
Journal:  Curr Opin Cell Biol       Date:  1996-04       Impact factor: 8.382

Review 3.  Regulation of phosphoinositide-specific phospholipase C isozymes.

Authors:  S G Rhee; Y S Bae
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

Review 4.  Signalling functions and biochemical properties of pertussis toxin-resistant G-proteins.

Authors:  T A Fields; P J Casey
Journal:  Biochem J       Date:  1997-02-01       Impact factor: 3.857

5.  Regulation of the expression of the tissue transglutaminase gene by DNA methylation.

Authors:  S Lu; P J Davies
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-29       Impact factor: 11.205

6.  Activation of the G protein Gq/11 through tyrosine phosphorylation of the alpha subunit.

Authors:  H Umemori; T Inoue; S Kume; N Sekiyama; M Nagao; H Itoh; S Nakanishi; K Mikoshiba; T Yamamoto
Journal:  Science       Date:  1997-06-20       Impact factor: 47.728

7.  Human G(alpha q): cDNA and tissue distribution.

Authors:  B Chen; R D Leverette; D A Schwinn; M M Kwatra
Journal:  Biochim Biophys Acta       Date:  1996-06-11

8.  Evidence that phospholipase delta1 is the effector in the Gh (transglutaminase II)-mediated signaling.

Authors:  J F Feng; S G Rhee; M J Im
Journal:  J Biol Chem       Date:  1996-07-12       Impact factor: 5.157

9.  Alpha1-adrenergic receptor signaling via Gh is subtype specific and independent of its transglutaminase activity.

Authors:  S Chen; F Lin; S Iismaa; K N Lee; P J Birckbichler; R M Graham
Journal:  J Biol Chem       Date:  1996-12-13       Impact factor: 5.157

10.  Cholinergic stimulation of AP-1 and NF kappa B transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: relationship to phosphoinositide hydrolysis.

Authors:  X Li; L Song; R S Jope
Journal:  J Neurosci       Date:  1996-10-01       Impact factor: 6.167

View more
  8 in total

Review 1.  Transglutaminase 2: a molecular Swiss army knife.

Authors:  Soner Gundemir; Gozde Colak; Janusz Tucholski; Gail V W Johnson
Journal:  Biochim Biophys Acta       Date:  2011-10-10

2.  Parathyroid hormone signaling through low-density lipoprotein-related protein 6.

Authors:  Mei Wan; Chaozhe Yang; Jun Li; Xiangwei Wu; Hongling Yuan; Hairong Ma; Xi He; Shuyi Nie; Chenbei Chang; Xu Cao
Journal:  Genes Dev       Date:  2008-11-01       Impact factor: 11.361

3.  G-protein-coupled receptor agonists activate endogenous phospholipase Cepsilon and phospholipase Cbeta3 in a temporally distinct manner.

Authors:  Grant G Kelley; Katherine A Kaproth-Joslin; Sarah E Reks; Alan V Smrcka; Richard J H Wojcikiewicz
Journal:  J Biol Chem       Date:  2005-11-28       Impact factor: 5.157

4.  Tissue transglutaminase overexpression does not modify the disease phenotype of the R6/2 mouse model of Huntington's disease.

Authors:  Ashish Kumar; Andrew Kneynsberg; Janusz Tucholski; Giselle Perry; Thomas van Groen; Peter J Detloff; Mathieu Lesort
Journal:  Exp Neurol       Date:  2012-06-12       Impact factor: 5.330

5.  The Differential Effects of R580A Mutation on Transamidation and GTP Binding Activity of Rat and Human Type 2 Transglutaminase.

Authors:  Qingmin Ruan; Janusz Tucholski; Soner Gundemir; Gail V W Johnson Voll
Journal:  Int J Clin Exp Med       Date:  2008-06-30

Review 6.  Comments on the mechanisms of action of radiation protective agents: basis components and their polyvalence.

Authors:  Mikhail V Vasin
Journal:  Springerplus       Date:  2014-08-07

7.  Anti-tissue transglutaminase antibodies from coeliac patients inhibit transglutaminase activity both in vitro and in situ.

Authors:  C Esposito; F Paparo; I Caputo; M Rossi; M Maglio; D Sblattero; T Not; R Porta; S Auricchio; R Marzari; R Troncone
Journal:  Gut       Date:  2002-08       Impact factor: 23.059

8.  Probing tissue transglutaminase mediated vascular smooth muscle cell aging using a novel transamidation-deficient Tgm2-C277S mouse model.

Authors:  Huilei Wang; James Chen; Sandeep Jandu; Sean Melucci; William Savage; Kavitha Nandakumar; Sara K Kang; Sebastian Barreto-Ortiz; Alan Poe; Shivam Rastogi; Maria Bauer; Jochen Steppan; Lakshmi Santhanam
Journal:  Cell Death Discov       Date:  2021-07-29
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.